Onset of inflammatory bowel disease [IBD] is nowadays seen as an interplay or a combination of genetic susceptibility, disturbed intestinal immunity, and environmental factors including gut microbiome. However, the initiation of inflammation and progression to IBD pathogenesis in a given individual is poorly understood. In this case report we describe the clinical course of a 17-yearold female patient developing symptoms suggestive of IBD after 'autovaccine therapy', in which sterilised samples of the patient's own stool were injected subcutaneously for improvement of her general immunity. The patient presented with a severe onset of disease, which was first suspected to be ulcerative colitis on outpatient examination and was later corrected to IBD with Crohn's-like features due to high systemic inflammation, mixed lymphocytic-granulocytic infiltrates in gastric biopsies, and further characteristics suggestive of Crohn's disease. A prolonged and complicated course was seen with intermittent steroid dependency in the long term. Numerous publications postulate that [auto-]immune reactions against resident bacterial stool flora may play a role in IBD. It is possible that in this patient tolerance to endogenous bacteria was disrupted by systemic proinflammatory mechanisms induced by autovaccination.
Introduction
The aetiology and causes for manifestation of chronic IBD in a given individual are still uncertain. Besides allergic, nutritional and infectious causes, autoimmune phenomena are postulated to play a role in the pathogenesis, in addition to disturbances in the immuneregulatory mechanisms of innate mucosal immunity and the adaptive immune system. 1 Reactions against resident bacterial flora are suspected to play a significant role in IBD. 
Case report

Presentation at initial admission and history
On hospital admission, the patient reported bloody diarrhoea [6-8 times a day], mucous fluid secretions, and crampy abdominal pain. Nausea and weight loss of 2 kg within the past week were present with a Crohn´s Disease Activity Index [CDAI] of 424 points. Proctosigmoiditis ulcerosa was suspected from outpatient sigmoidoscopy and hospitalisation was necessary because of inadequate response to mesalamine, rectal betamethasone, budesonide, and disodium cromoglycate. 5 The 17-year-old girl had suffered from Hymenoptera allergy since childhood. Vaccinations to measles, mumps, rubella, and pertussis were inconspicuous. Chickenpox appeared at the age of 6 months. At the age of 7 years, IgE values were > 1 000 U/ml [normally < 100 U/ml], but no other atopic manifestation was present. Since starting smoking aged 17, the patient suffered frequent upper respiratory and urinary tract infections without gastrointestinal symptoms, and one manifestation of herpes zoster [shingles] . To improve her general immunity, 'autovaccine therapy' was administered by an alternative practitioner. The vaccines were prepared to mainly contain Escherichia coli, but the presence of other microorganisms was not definitely excluded. In principle, the aim was to separate E. coli from the stools using culture techniques. Afterwards, the culture was sterilised and injected subcutaneously over a period of 3 months in increasing concentrations of 1000-10 000 bacilli/ml, suspended in isotonic saline and conserved with 0.25% phenol. After the last of three injections, an exanthema occurred at the site of previous shingles manifestation, traces of blood appeared in stools, and after several days of constipation, bloody diarrhoea progressed to severe colitis.
Family history was negative for IBD, coeliac disease, lymphoma, autoimmunopathy, vasculitis, and neoplasia. Except for Hymenoptera allergy, the patient showed no atopic or allergic manifestations before onset of disease. ). The pulse was regular at 70 beats per min, blood pressure 95/55-120/70 mmHg, pulmonary examination unremarkable, liver 12 cm in the medial clavicular line, palpable under costal arch. Diffuse pain upon palpation was accentuated over the distal bowels and the right side. Rectal examination evoked pain in the pouch of Douglas and blood on the glove. Renal, musculoskeletal, vascular, and nervous systems were normal, as was psychological status [for laboratory results see Tables 1 and 2 ].
Physical examination at admission
Diagnostic investigations
Colonoscopy showed severe pancolitis with pronounced cobblestone pattern, oedematous mucosal swelling, multiple erosions, and discontinuous longitudinal ulcerations throughout the colon, but no inflammation in the ileum [ Figures 1 and 2 ]. Histological examination revealed severe Helicobacter pylori negative gastritis with small foci of destruction of the epithelium [ Figure 3 ]. Mixed lymphocyticgranulocytic infiltrates were observed focally within stomach samples, with colon and stomach free of granulomatous lesions. However, some thickened small bowel segments were detected later by transabdominal ultrasonography. After exclusion of infection, humoral/cellular immunodeficiency, and other diseases, the final diagnosis of Crohn's disease [CD] was made based on pancolitis with macroscopic features resembling CD, focally active gastritis, and severe systemic inflammation [ Tables 1 and 2 ].
Initial treatment and clinical response to steroids
Parenteral nutrition was administered and high-dose steroid treatment initiated. Prednisone treatment [initially 1.5 mg/kg] along with high-dose salicylates and topical budesonide induced a slowly ongoing, but only moderate clinical response. CDAI was 179 points after 6 weeks, but stool frequency remained increased. Trials to finish steroid treatment led to intermittent flare-ups of the disease, so steroid doses between 12-24 mg/day prednisonewere necessary.
Subsequent course and follow up
In view of steroid dependency after 2 months of treatment, azathioprine therapy [75 mg/day] was introduced, resulting in less frequent [2 x day] and formed stools. Nutritional therapy was administered: a potato and rice diet, with careful addition of other foodstuffs every 3 days. An additional adjuvant nutritional supplement was given daily with an amino acid preparation [E028®]. 5 After initial remission, a slight reactivation of the colitis occurred [4-5 stools/day] with intense belt-like pain and high lipase levels [1160 U/l, normal: 1360 U/l], indicating azathioprine-induced pancreatitis. Azathioprine was immediately discontinued after confirmation by magnetic resonance cholangiopancreatography . Parenteral nutrition was given for 10 further days until pancreatitis symptoms improved. Interestingly, IBD activity also decreased under this therapy. Prednisone could then be gradually reduced from 8 mg to 4 mg daily over 3 months and stopped after another 3 months. Follow up colonoscopy revealed unspecific non-erosive and some erosive colonic lesions, but histologically moderate inflammation was present. CDAI varied in the long term between 75-218 points. As the patient declined further immunosuppressive medication, intermittent steroid doses [15-25 mg daily] were required for long-term IBD management.
Discussion
Currently, onset of IBD is regarded as an interplay between genetic susceptibility, disturbed intestinal immunity, and environmental factors including gut microbiome or pathogenic infections.
2,3,4,6,7,8 As stool cultures for established pathogenic agents in IBD patients are mostly negative, an abnormal immune reaction against resident commensal bacteria is currently suspected for IBD pathogenesis. Here, we report on a severe side-effect of subcutaneously-injected own sterilised stool in an atopic patient, which resulted in onset of a severe colitis with Crohn's-like features requiring long-term intermittent steroid therapy. Multiple alternative aetiologies for this severe flare-up of IBD were excluded [viral/bacterial infections, autoimmunopathy, vasculitis, etc Table 1 ]. There were no gastrointestinal symptoms or signs of infection at the time of stool collection for autovaccination. It is likely that several mechanisms via antigenic stimulation by a common antigen of commensal gut flora played a role in the exacerbation of systemic immune response. First, the autovaccine was prepared to mainly contain E.coli, thus it may be speculated whether repeated challenge of E. coli antigens [eg flagellin, CBir 1, etc] may have induced a pro-inflammatory reaction and/or whether the patient's genetic predisposition for recognition of certain bacterial antigens was causally responsible for inflammation induction. 9 We could not perform further genetic testing, but antibody responses to p-ANCA/ASCA were negative. 9, 10 Second, from allergen immunotherapy it is known that injection of antigens can cause activation of dendritic cells and trigger adaptive immune regulation with IgG and/or IgM antibody production. 11, 12 This might have induced an effector reaction of Th1 cells, cytotoxic lymphocytes, and/or natural killer cells [NK cells]. 13, 14 The absence of gut inflammation before autovaccination suggests that intestinal tolerance to commensal microbial flora was present. Thus, autovaccination might have damaged intestinal tolerance, and finally led to systemic immune activation. This is supported by clearly enhanced sIL-2R and moderately enhanced tumour necrosis factor [TNF] concentrations, whereas IL-10 was only slightly increased at disease manifestation [ Table 2 ]. Van der Waaij 15 showed IBD patients to have an increased percentage of IgA-, IgG-, and IgM immunoglobulin-coated anaerobic bacteria in their faeces, indicating the breakdown of mucosal tolerance. 16 Assuming that no error occurred in the sterilisation of stool samples, we cautiously speculate that increased systemic, probably IgG/IgM, or cellular immune response against ingredients of the stool induced this massive inflammatory response.
Third, allergic hypersensitivity mediated by IgE-and Th2 response against stool antigens appears theoretically possible in an atopic individual, but classical immunotherapy has shown that subcutaneous application of antigens usually causes IgG1, IgG4, and other IgG class antibody formation, 12, 13, 17 thus an allergic reaction appears unlikely. Autovaccines are primarily used for chronic inflammatory diseases such as acne vulgaris, 18 dust-mite induced asthma, 19 and vulvovaginal candidiasis. 20 The precise mechanisms are not yet understood, but it may include the release of cytokines, 21 inhibition of mast cells/basophils, 17 and cellular up-regulation of suppressing 22 and activating 18 cells. However, up to now no systematic research on T cell proliferation in response to autovaccines has been undertaken, and this is the first case report of IBD manifestation subsequent to autovaccine therapy. In light of the unremarkable family history, negative p-ANCA/ ASCA at disease manifestation, and absence of gastrointestinal disease before autovaccination, it seems unlikely that IBD manifestation occurred independently of the autovaccination. Thus, subcutaneous autovaccine therapy should be critically regarded in IBD patients.
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